Home › Therapeutic areas › Metabolic › Hypoparathyroidism

Hypoparathyroidism (3 companies)

Companies with an active program in Hypoparathyroidism.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ENTX Entera Bio GI/HepatologyMetabolic Rare 1 Phase 2 $522M 4
MBX MBX Biosciences Metabolic Rare 1 Phase 3 $2.64B 4
SEPN Septerna ImmunologyMetabolic+1 Rare 1 Phase 1 $1.90B 5